Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 640 results for "clopidogrel"

ISAR-TRIPLE: Six-Week vs Six-Month Clopidogrel in DES and AF

My name is Nikolaus Sarafoff, from Munich, and I want to present the results of the ISAR-TRIPLE trial, which I had the honor to present on behalf of all coauthors at the TCT convention in Washington. Patients with an indication for oral ... Medscape, 10 hours ago

7 images for clopidogrel

Journal of Clinical Pharmacology, 2 months ago
Newswise, 3 months ago
Med India, 4 months ago
MedPage Today, 4 months ago
PitchEngine, 4 months ago
PitchEngine, 4 months ago
Scoop Asia, 5 months ago

Human medicines European public assessment report (EPAR): Clopidogrel/Acetylsalicylic acid Teva, clopidogrel / acetylsalicylic acid, Revision: 0, Authorised

This is a summary of the European public assessment report (EPAR) for Clopidogrel/Acetylsalicylic acid Teva. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to ...
 European Medicines Agency2 days ago

TRANSLATE-ACS: No MACE Benefit With Prasugrel in ACS

WASHINGTON, DC — A real-world comparison of clopidogrel vs prasugrel (Effient, Lilly/Daiichi-Sankyo) in nearly 12 000 acute coronary syndrome (ACS) patients undergoing PCI revealed no significant differences in the rate of major adverse ...
 American Journal of Public Health1 week ago TRANSLATE-ACS: A Large-Scale Registry Comparing Patterns of Use and One-Year Outcomes with Prasugrel Versus Clopidogrel in Patients with Acute Myocardial Infarction Undergoing___  TCTMD.com2 weeks ago

Ticagrelor vs Clopidogrel in Non-ST-Elevation ACS

Bax JJ, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S ...
 General Medicine eJournal2 weeks ago

Advancement of Ascendia Pharmaceutical's Nano-Emulsion Technology Platform with Its Lead Development Program ASD-002

There is a significant unmet medical need for a parenteral clopidogrel dosage form for the treatment of Acute Coronary Syndrome under life-threatening situations, said Jingjun Jim Huang, Ph.D ., CEO of Ascendia. With our ...
 Morningstar.com3 weeks ago Ascendia Applies Nano-Emulsion Technology to Injectable Blood Thinner Medicine  Azonano3 weeks ago Advancement of Ascendia's nano-emulsion technology platform with Its lead development program ASD-002  Pharmaceutical Business Review3 weeks ago
[x]  

Clopidogrel response impaired among patients with diabetes, CAD

Patients with diabetes and CAD experienced an impaired response to platelet P2Y12 receptor antagonist clopidogrel compared with those without diabetes in a recent prospective study. The researchers attributed the difference primarily to reduced ...
 Orthopedics Today3 weeks ago Impaired Responsiveness to the PlateletP2Y 12 Receptor Antagonist ClopidogrelinPatients With Type 2 Diabetes andCoronary Artery Disease  Journal of the American College of Cardiology4 weeks ago Diabetes Mellitus and Clopidogrel Response Variability ∗  Journal of the American College of Cardiology4 weeks ago DAIICHI SANKYO : Report Summarizes Diabetes Study Findings from Daiichi Sankyo [Impaired Responsiveness to the Platelet P2Y(12) Receptor Antagonist Clopidogrel in...  4 Traders1 week ago

New and Generic Drug Approvals: Clopidogrel

Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to
 U.S. Food and Drug Administration2 weeks ago

Vorapaxar with or without clopidogrel after nonST-segment elevation acute coronary syndromes: Results from the TRACER trial - Accepted Manuscript

European Online Customer Service The Boulevard Langford Lane, Kidlington Oxford. OX5 1GB UK Hours: Monday - Friday, 8:30am - 5:00pm (Greenwich Mean Time/British Summer Time) Tel: +44 (0) 1865-843177 (Within Europe) Fax: +44 (0) ...
 American Heart Journal2 weeks ago Impact of Diabetes Mellitus and Metabolic Syndrome on Acute and Chronic On-Clopidogrel Platelet Reactivity in Patients With Stable Coronary Artery Disease Undergoing Drug-Eluting Stent Placement - Accepted Manuscript  American Heart Journal2 weeks ago Does baseline hematocrit influence the assays of on-treatment platelet reactivity to clopidogrel? - Corrected Proof  American Heart Journal1 month ago

Stent Thrombosis After MI Is Higher With Clopidogrel Than Prasugrel in in Real World Setting: Presented at TCT

You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: You can also: Wait 3 days for your content allowance to be renewed. Sign up for a free trial to ...
 FirstWord Pharma2 weeks ago

TCT-502 Efficacy and safety of switching from clopidogrel to prasugrel in diabetic patients with acute coronary syndromes treated with drug-elunting stents: results of the ESCAPADA study

Note: Since your browser does not support Javascript, you must press the Continue button once
 Journal of the American College of Cardiology3 weeks ago TCT-492 Stent Thrombosis With Ticagrelor Versus Clopidogrel After Percutaneous Coronary Intervention and Ticagrelor or Clopidogrel in Patients With Acute Coronary Syndromes in a Real World Setting  Journal of the American College of Cardiology3 weeks ago TCT-480 Prior Clopidogrel Therapy in Patients Presenting with Acute Coronary Syndromes (ACS) is Associated with Increase Risk of Stent Thrombosis  Journal of the American College of Cardiology3 weeks ago TCT-499 Comparable outcomes on single use of clopidogrel vs. dual antiplatelet therapy after coronary stenting in patients with acute myocardial infarction  Journal of the American College of Cardiology3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less